B2M and Sjogren syndrome: Patients with active primary Sjögren’s syndrome, notably those with increased systemic disease activity (302) and history of lymphoma (303, 304), and hemophagocytic lymphohistiocytosis (305) were also found to have elevated urinary β2M level.